TY - JOUR
T1 - Hepatitis A antibody prevalence among young adults in Israel - The decline continues
AU - Gdalevich, M.
AU - Grotto, I.
AU - Mandel, Y.
AU - Mimouni, D.
AU - Shemer, J.
AU - Ashkenazi, I.
PY - 1998/10
Y1 - 1998/10
N2 - This study sought to determine whether the decline in prevalence of hepatitis A virus (HAV) antibodies detected in Israel in 1977, 1984, and 1987 has continued. The anti-HAV antibody prevalence of a systematic sample of 578 male and female recruits inducted into the Israel Defence Force in 1996 was 38.4%. The reduction in antibody prevalence from 1977 (64%) was highly significant (P < 0.001). There was a smaller decrease rate in recruits of European, North American, Australian and South African origin than from elsewhere. A 'strategy' that uses active immunization against hepatitis A (inactivated vaccine, instead of gamma globulin) should be considered, particularly in high risk groups such as field units during military service.
AB - This study sought to determine whether the decline in prevalence of hepatitis A virus (HAV) antibodies detected in Israel in 1977, 1984, and 1987 has continued. The anti-HAV antibody prevalence of a systematic sample of 578 male and female recruits inducted into the Israel Defence Force in 1996 was 38.4%. The reduction in antibody prevalence from 1977 (64%) was highly significant (P < 0.001). There was a smaller decrease rate in recruits of European, North American, Australian and South African origin than from elsewhere. A 'strategy' that uses active immunization against hepatitis A (inactivated vaccine, instead of gamma globulin) should be considered, particularly in high risk groups such as field units during military service.
UR - http://www.scopus.com/inward/record.url?scp=0031757750&partnerID=8YFLogxK
U2 - 10.1017/S0950268898001198
DO - 10.1017/S0950268898001198
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
AN - SCOPUS:0031757750
SN - 0950-2688
VL - 121
SP - 477
EP - 479
JO - Epidemiology and Infection
JF - Epidemiology and Infection
IS - 2
ER -